OSM and melanoma: Although OSM was initially described as an antiproliferative cytokine inhibiting the growth of melanoma, breast cancer, chondrosarcoma, lung adenocarcinoma, and glioblastoma cells [1,40,41,42,43], it has also been shown to promote proliferation in various cell lines [44,45,46,47,48,49].